Obritsch MD - Search Results

1

Effects of continuous vasopressin infusion in patients with septic shock.

Obritsch MD, Jung R, Fish DN, MacLaren R. Obritsch MD, et al. Ann Pharmacother. 2004 Jul-Aug;38(7-8):1117-22. doi: 10.1345/aph.1D513. Epub 2004 Jun 3. Ann Pharmacother. 2004. PMID: 15178740

2

The role of vasopressin in vasodilatory septic shock.

Obritsch MD, Bestul DJ, Jung R, Fish DN, MacLaren R. Obritsch MD, et al. Pharmacotherapy. 2004 Aug;24(8):1050-63. doi: 10.1592/phco.24.11.1050.36144. Pharmacotherapy. 2004. PMID: 15338853 Review.

3

Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study.

Kiser TH, Fish DN, Obritsch MD, Jung R, MacLaren R, Parikh CR. Kiser TH, et al. Among authors: obritsch md. Nephrol Dial Transplant. 2005 Sep;20(9):1813-20. doi: 10.1093/ndt/gfh930. Epub 2005 Jun 14. Nephrol Dial Transplant. 2005. PMID: 15956066

4

Efflux pump contribution to multidrug resistance in clinical isolates of Pseudomonas aeruginosa.

Kiser TH, Obritsch MD, Jung R, MacLaren R, Fish DN. Kiser TH, et al. Among authors: obritsch md. Pharmacotherapy. 2010 Jul;30(7):632-8. doi: 10.1592/phco.30.7.632. Pharmacotherapy. 2010. PMID: 20575627

5

Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital.

Jung R, Fish DN, Obritsch MD, MacLaren R. Jung R, et al. Among authors: obritsch md. J Hosp Infect. 2004 Jun;57(2):105-11. doi: 10.1016/j.jhin.2004.03.001. J Hosp Infect. 2004. PMID: 15183239

6

National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002.

Obritsch MD, Fish DN, MacLaren R, Jung R. Obritsch MD, et al. Antimicrob Agents Chemother. 2004 Dec;48(12):4606-10. doi: 10.1128/AAC.48.12.4606-4610.2004. Antimicrob Agents Chemother. 2004. PMID: 15561832 Free PMC article.

7

Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.

Obritsch MD, Fish DN, MacLaren R, Jung R. Obritsch MD, et al. Pharmacotherapy. 2005 Oct;25(10):1353-64. doi: 10.1592/phco.2005.25.10.1353. Pharmacotherapy. 2005. PMID: 16185180 Review.

8

Levofloxacin pharmacokinetics and pharmacodynamics in patients with severe burn injury.

Kiser TH, Hoody DW, Obritsch MD, Wegzyn CO, Bauling PC, Fish DN. Kiser TH, et al. Among authors: obritsch md. Antimicrob Agents Chemother. 2006 Jun;50(6):1937-45. doi: 10.1128/AAC.01466-05. Antimicrob Agents Chemother. 2006. PMID: 16723549 Free PMC article.

9

Acute ethanol intoxication after consumption of hairspray.

Carnahan RM, Kutscher EC, Obritsch MD, Rasmussen LD. Carnahan RM, et al. Among authors: obritsch md. Pharmacotherapy. 2005 Nov;25(11):1646-50. doi: 10.1592/phco.2005.25.11.1646. Pharmacotherapy. 2005. PMID: 16232026

10

Antimicrobial symposium. Part VIII. Glycopeptides, oxazolidinones, and lipopeptides.

Hoffman-Roberts HL, Obritsch MD, Bronze MS, Greenfield RA. Hoffman-Roberts HL, et al. Among authors: obritsch md. J Okla State Med Assoc. 2007 Apr;100(4):105-11. J Okla State Med Assoc. 2007. PMID: 17476993 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters